# Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

> **NCT07682454** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 50 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Liver Cancer, Adult

## Interventions

- **PROCEDURE:** Parenchymal Blood Volume (PBV) Imaging
- **DRUG:** Nitroglycerin
- **OTHER:** Medical Record Review

## Key facts

- **NCT ID:** NCT07682454
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682454, "Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07682454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*